TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,372 | +928.2% | 6,017 | +710.9% | 0.00% | – |
| Q4 2022 | $1,106 | +10.6% | 742 | -15.5% | 0.00% | – |
| Q3 2022 | $1,000 | -92.3% | 878 | -81.8% | 0.00% | – |
| Q1 2022 | $13,000 | – | 4,828 | +5580.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 85 | -96.1% | 0.00% | – |
| Q2 2021 | $14,000 | -39.1% | 2,190 | -22.8% | 0.00% | – |
| Q1 2021 | $23,000 | 0.0% | 2,838 | -38.5% | 0.00% | – |
| Q3 2020 | $23,000 | -4.2% | 4,612 | -63.5% | 0.00% | – |
| Q2 2020 | $24,000 | +1100.0% | 12,649 | +911.9% | 0.00% | – |
| Q1 2020 | $2,000 | -77.8% | 1,250 | -66.5% | 0.00% | – |
| Q4 2019 | $9,000 | – | 3,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |